Clinical Trial Update: Hong Kong Cardiogenic Shock Initiative

View source ↗

Summary

A clinical trial in Hong Kong is studying the management of cardiogenic shock in STEMI patients. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Cardiogenic Shock Post Myocardial Infarction
• St-elevation Myocardial Infarction

Snippet

Sponsor: Prince of Wales Hospital, Shatin, Hong Kong | Conditions: Cardiogenic Shock Acute, STEMI - ST Elevation Myocardial Infarction | Status: NOT_YET_RECRUITING